CSIMarket
 
Aethlon Medical Inc   (AEMD)
Other Ticker:  
 
 
Price: $0.6930 $0.01 0.873%
Day's High: $0.74 Week Perf: 23.64 %
Day's Low: $ 0.60 30 Day Perf: 73.25 %
Volume (M): 10,936 52 Wk High: $ 2.35
Volume (M$): $ 7,579 52 Wk Avg: $1.18
Open: $0.62 52 Wk Low: $0.20



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) -
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -13
 Cash Flow (TTM) (Millions $) -9
 Capital Exp. (TTM) (Millions $) 1

Aethlon Medical Inc
Aethlon Medical Inc is a medical technology company that focuses on the development of therapeutic devices to address infectious diseases, cancer, and other life-threatening conditions. The company's flagship product is the Aethlon Hemopurifier, which is designed to remove certain targeted agents from the circulatory system. This device is currently being studied as a potential treatment for viral infections, including HIV and hepatitis C.

In addition to the Hemopurifier, Aethlon Medical is also engaged in the development of exosomes-based technology called the ESI platform, which is designed to diagnose and monitor the progression of cancer. The company has collaborations with various research institutes and healthcare organizations for the advancement of its products.

Aethlon Medical was founded in 1991 and is headquartered in San Diego, California. The company aims to provide innovative and effective treatments for life-threatening conditions through its therapeutic devices and technologies.


   Company Address: 11555 SORRENTO VALLEY ROAD SAN DIEGO 92121 CA
   Company Phone Number: 941-0360   Stock Exchange / Ticker: NASDAQ AEMD
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Aethlon Medical Inc

Small but Mighty: A Closer Look at Aethlon Medical Inc's Operating Shortfall



The stock market is constantly buzzing with the performance of large companies, but it's important not to overlook the potential of smaller corporations. In the Medical Equipment & Supplies sector, emerging growth companies are making their mark, and one such company is Aethlon Medical Inc.
Operating Shortfall:
AEMD, an emerging growth corporation in the Medical Equipment & Supplies sector, recently disclosed an operating shortfall of $-3.567088 million for the third quarter of 2024. While the company has not revealed its revenue figures yet, analyzing their business achievements from the third quarter of 2023 provides some interesting insights.

Aethlon Medical Inc

Aethlon Medical Inc Announces Improved Financial Results in Q2 2024 Despite Operating Deficit



Aethlon Medical Inc, a leading player in the Medical Equipment & Supplies sector, has demonstrated remarkable growth in its share prices in recent times. With shares increasing by 0.29% during the past 5 trading days and a staggering year-to-date performance of 503.36%, the company's prospects appear promising. Furthermore, trading on the NASDAQ at 226.2% above its 52-week average, Aethlon Medical Inc has garnered attention from investors and analysts alike. Nonetheless, interpreting the latest financial results, particularly the operating deficit and the company's efforts to minimize losses, will provide a clearer perspective on its future trajectory.
Financial Results and Analysis:
Within the Medical Equipment & Supplies sector, Aethlon Medical Inc has caught the attention of industry observers as they begin analyzing the second quarter of 2024 earnings. For the July to September 30, 2023 financial reporting period, the company reported an operating deficit of $-3.175346 million. Even though no revenue was stated for this period, this deficit showcases promising progress.

Aethlon Medical Inc

Aethlon Medical Inc Faces Mounting Expenses and Deepening Operating Deficit, Raising Concerns for Future Performance

Aethlon Medical Inc Faces Operating Deficit in 1Q 2023, Prompting Concerns for Future Performance
Medical equipment and supplies industry advisors have recently turned their attention to the financial numbers of Aethlon Medical Inc for the first quarter of 2023. The analysis reveals an operating deficit of $-3.40816 million during the April to June 30 reporting season, without any mention of top-line figures. This situation raises concerns among investors regarding the company's future performance.
Comparing the operating deficit of the first quarter of 2023, which stood at $-2.906081 million, it becomes evident that the shortfall has worsened in the April to June 30 2023 interval. The current shortfall is reported to be $-3.282 million, representing a significant increase from the previous quarter. With the absence of any mention of top-line numbers, this further adds to the uncertainty surrounding Aethlon Medical Inc's financial situation.

Aethlon Medical Inc

Outstanding 4147.697% YoY Revenue Spike for AEMD in Q4 2023 Despite Losses


Introduction:
Aethlon Medical Inc, a leading player in the Medical Equipment & Supplies industry, recently reported its financial results for the period ending March 31, 2023. The company demonstrated a remarkable revenue improvement of 4147.697% year on year, reaching $0.56 million. However, the news wasn't entirely positive, as the company incurred a net loss of $-0.12 per share. With such contrasting figures, it raises questions about the company's future prospects and how these results will impact its overall performance.
Solid Revenue Growth:
Aethlon Medical's monumental revenue growth is undoubtedly an encouraging sign. The company managed to achieve an astonishing 4147.697% increase, boosting its revenue to reach $0.56 million compared to the previous reporting season's $0.00 million. Such remarkable growth may indicate the successful implementation of the company's strategic initiatives and enhanced market penetration.






 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com